直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Offices
  • Careers
Finnegan
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • IP Health Blog
    • Prosecution First Blog
  • Articles
  • IP Updates
  • Podcasts
  • Events
  • Webinars
  • Books

Webinar

Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation

February 16, 2022

Webinar

Strafford Publications

As part of the Strafford Publications’ webinar series, Finnegan partners Mark Feldstein and David Weingarten will review the FDA's recent guidance on biologics and biosimilars and how it impacts patent strategy. For more information, or to register, please see Strafford’s website.

Tags

Food and Drug Administration (FDA)

Related Practices

Patent Litigation

Patent Office Examinations

Prosecution

Related Industries

Life Sciences

Pharmaceutical

Biologics

Related Professionals

Mark_Feldstein
Mark J. Feldstein, Ph.D.
Partner
Washington, DC
+1 202 408 4092
Email
David_Weingarten
M. David Weingarten, Ph.D.
Partner
Atlanta, GA
+1 404 653 6457
Email

Related Insights

Conference

2022 AIPPI World Congress

September 10-13, 2022

San Francisco

Webinar

PTAB Litigation Strategies for 2022 and Beyond

September 1, 2022

Webinar

IP Updates

Unitary Patent FAQ

2022

IP Updates

Strategic Considerations for Opting In or Out of the Unified Patent Court

2022

IP Updates

The Unified Patent Court FAQ

2022

Webinar

Patent Infringement After Duncan Parking Technologies: Doctrine of Equivalents, Claim Construction

August 18, 2022

Webinar

Prosecution First Blog

Prosecution Pointer 342

August 17, 2022

Prosecution First Blog

The CCPA’s Influence on Obviousness-Type Double Patenting Jurisprudence

August 12, 2022

Prosecution First Blog

Prosecution Pointer 341

August 10, 2022

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

If you have European patents, you need to know about the Unified Patent Court (UPC).

Finnegan
Click Here
  • Privacy
  • Disclaimer
  • EEO Statement

© 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP